Article info

Download PDFPDF
Original research
Two-year regional grey and white matter volume changes with natalizumab and fingolimod

Authors

  • Paolo Preziosa Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Maria A Rocca Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Elisabetta Pagani Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Loredana Storelli Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Mariaemma Rodegher Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Lucia Moiola Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Massimo Filippi Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Prof. Massimo Filippi, Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; filippi.massimo{at}hsr.it
View Full Text

Citation

Preziosa P, Rocca MA, Pagani E, et al
Two-year regional grey and white matter volume changes with natalizumab and fingolimod

Publication history

  • Received November 13, 2019
  • Revised February 3, 2020
  • Accepted February 4, 2020
  • First published February 28, 2020.
Online issue publication 
April 15, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.